{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:14:14Z","timestamp":1761743654201,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T00:00:00Z","timestamp":1340928000000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.6061\/clinics\/2012(06)01","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T13:28:37Z","timestamp":1339507717000},"page":"543-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation"],"prefix":"10.1016","volume":"67","author":[{"given":"Antonio","family":"de Padua Mansur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio Yoshio","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange Desiree","family":"Avakian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia M.C.","family":"Strunz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6 supl.1","key":"10.6061\/clinics\/2012(06)01_bib1","first-page":"1","volume":"92","author":"Zimerman","year":"2009","journal-title":"Sociedade Brasileira de Cardiologia. Diretrizes Brasileiras de Fibrila\u00e7\u00e3o Atrial. Arq Bras Cardiol"},{"issue":"4","key":"10.6061\/clinics\/2012(06)01_bib2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1067\/mhj.2003.91","article-title":"Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation","volume":"145","author":"Stoddard","year":"2003","journal-title":"Am Heart J"},{"issue":"11","key":"10.6061\/clinics\/2012(06)01_bib3","first-page":"592","article-title":"Anticoagulation for atrial fibrillation: underutilization in a Brazilian tertiary outpatient clinic","volume":"27","author":"Mesas","year":"2004","journal-title":"Clin Cardiol"},{"issue":"3","key":"10.6061\/clinics\/2012(06)01_bib4","first-page":"244","article-title":"Meta-Analysis to Assess the Quality of Warfarin Control in Atrial Fibrillation Patients in the United States","volume":"15","author":"Baker","year":"2009","journal-title":"J Manage Care Pharm"},{"issue":"9028","key":"10.6061\/clinics\/2012(06)01_bib5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(96)03487-3","article-title":"Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke prevention in atrial fibrillation III randomised clinical trial","volume":"348","author":"Blackshear","year":"1996","journal-title":"Lancet"},{"issue":"18","key":"10.6061\/clinics\/2012(06)01_bib6","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1093\/eurheartj\/ehr134","article-title":"Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA","volume":"32","author":"Wieloch","year":"2011","journal-title":"Eur Heart J"},{"issue":"10","key":"10.6061\/clinics\/2012(06)01_bib7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.7326\/0003-4819-141-10-200411160-00005","article-title":"Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation","volume":"141","author":"Fang","year":"2004","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.6061\/clinics\/2012(06)01_bib8","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.amjcard.2011.06.017","article-title":"Practice-Level Variation in Warfarin Use Among Outpatients With Atrial Fibrillation (from the NCDR PINNACLE Program)","volume":"108","author":"Chan","year":"2011","journal-title":"American Journal of Cardiology"},{"issue":"5","key":"10.6061\/clinics\/2012(06)01_bib9","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1160\/TH11-05-0353","article-title":"Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients","volume":"106","author":"Gallagher","year":"2011","journal-title":"Thromb Haemostasis"},{"year":"1996","series-title":"Primer of Biostatistics, version 4.02","key":"10.6061\/clinics\/2012(06)01_bib10"},{"issue":"3","key":"10.6061\/clinics\/2012(06)01_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archinte.167.3.239","article-title":"Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control - Results from SPORTIF III and IV","volume":"167","author":"White","year":"2007","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.6061\/clinics\/2012(06)01_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.thromres.2008.09.016","article-title":"Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR control","volume":"124","author":"Morgan","year":"2009","journal-title":"Thromb Res"},{"issue":"4","key":"10.6061\/clinics\/2012(06)01_bib13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/hrt.2004.042465","article-title":"Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population","volume":"91","author":"Jones","year":"2005","journal-title":"Heart"},{"issue":"7","key":"10.6061\/clinics\/2012(06)01_bib14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.amjmed.2009.11.025","article-title":"Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review","volume":"123","author":"Ogilvie","year":"2010","journal-title":"Am J Med"},{"issue":"7","key":"10.6061\/clinics\/2012(06)01_bib15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa035422","article-title":"Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism","volume":"349","author":"Kearon","year":"2003","journal-title":"New Engl J Med"},{"issue":"4","key":"10.6061\/clinics\/2012(06)01_bib16","first-page":"230","article-title":"Should Patient Characteristics Influence Target Anticoagulation Intensity for Stroke Prevention in Nonvalvular Atrial Fibrillation","volume":"2","author":"Singer","year":"2009","journal-title":"The ATRIA Study. Circ-Cardiovasc Qual"},{"issue":"11","key":"10.6061\/clinics\/2012(06)01_bib17","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jama.2011.1332","article-title":"High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI","volume":"306","author":"Parodi","year":"2011","journal-title":"JAMA: the journal of the American Medical Association"},{"issue":"5","key":"10.6061\/clinics\/2012(06)01_bib18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood-2009-02-207928","article-title":"Outcomes and predictors of very stable INR control during chronic anticoagulation therapy","volume":"114","author":"Witt","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.6061\/clinics\/2012(06)01_bib19","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1538-7836.2010.03756.x","article-title":"Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users","volume":"8","author":"Witt","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.6061\/clinics\/2012(06)01_bib20","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jacc.2006.07.009","article-title":"ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation \u2013 Executive summary","volume":"48","author":"Fuster","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.6061\/clinics\/2012(06)01_bib21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1592\/phco.30.4.330","article-title":"Comparison of Two Different Models of Anticoagulation Management Services with Usual Medical Care","volume":"30","author":"Rudd","year":"2010","journal-title":"Pharmacotherapy"},{"issue":"7","key":"10.6061\/clinics\/2012(06)01_bib22","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1592\/phco.31.7.686","article-title":"Health Care Expenditures and Therapeutic Outcomes of a Pharmacist-Managed Anticoagulation Service versus Usual Medical Care","volume":"31","author":"Hall","year":"2011","journal-title":"Pharmacotherapy"},{"issue":"13","key":"10.6061\/clinics\/2012(06)01_bib23","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2146\/ajhp080278","article-title":"International Normalized Ratio values in group versus individual appointments in a pharmacist-managed anticoagulation clinic","volume":"66","author":"Griffin","year":"2009","journal-title":"Am J Health-Syst Ph"},{"issue":"5","key":"10.6061\/clinics\/2012(06)01_bib24","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1055\/s-0037-1613888","article-title":"A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation","volume":"83","author":"Watzke","year":"2000","journal-title":"Thromb Haemostasis"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222017860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222017860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-67-06\/cln-67-06-543.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:07:37Z","timestamp":1761721657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222017860"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322012000600001&lng=en&nrm=iso&tlng=en","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3370303\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1807593222017860"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2012(06)01","relation":{},"ISSN":["1807-5932"],"issn-type":[{"type":"print","value":"1807-5932"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2012(06)01","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}